Monday, May 23, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

CDC RFI: Collection of Specimens During Outbreak or Public Health Emergency

by Global Biodefense Staff
June 17, 2019
Vials of biological samples taken during an outbreak by public health professional

Credit: Shutterstock

Infectious disease outbreaks, even small or remote ones, may be global threats and require a swift public health response. Accurate, accessible, and robust diagnostic tests are critical for patient management and public health response. However, when a new threat emerges, such as the Zika virus, diagnostic tests may not exist and have to be rapidly developed and implemented by public health and clinical laboratories to support response efforts.

During emergencies, access to samples and reference materials needed for test development, performance evaluation, and deployment is a challenge for CDC programs, public health partners, and private diagnostics manufacturers. A recent GAO report (GAO-17-445) showed that manufacturers of diagnostic assays experienced difficulty obtaining Zika positive clinical specimens, hindering the development of new Zika diagnostics.

To address the need for rapid access to outbreak-related samples, the CDC is interested in developing the capability to rapidly document informed consent and collect specimens from affected patients during outbreaks of infectious disease or public health emergencies.

CDC is seeking information from companies and other organizations about their capability and capacity to deploy to the site of a domestic or international outbreak or public health emergency, obtain informed consent, collect specimens (blood, urine, swabs, etc.) from identified patients, and safely ship these specimens to CDC in accordance with all applicable local, state, and federal and/or international laws, and regulations.

Additionally, the agency is seeking to obtain information, needs, capabilities, constraints, capacities, and requirements of those vendors and companies who do have an interest (or potential interest) in providing the needed services.

Further information is available via Solicitation Number: 75D301-19-Q-70417.

Tags: RFI

Related Posts

NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster
Preparedness

Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

May 6, 2022
U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity
Biosecurity

U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity

April 13, 2022
Yersinia pestis
Funding News

NIH Awards $3M Grant to Albany Med for Plague Vaccine Development

April 8, 2022
Load More

Latest News

NIH to Further Invest in Point-of-Care Technologies Research Network

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022

How a COVID-19 Infection Spurs Antibodies Against Common Colds

May 8, 2022
Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

May 6, 2022
Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

May 6, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC